Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Headache in multiple sclerosis and autoimmune disorders.
Factors associated with onset, relapses or progression in multiple sclerosis: A systematic review.
Natalizumab treatment for multiple sclerosis.
Is the incidence of optic neuritis rising? Evidence from an epidemiological study in Barcelona (Spain), 2008-2012.
Age-related Shift in Neural Complexity Related to Task Performance and Physical Activity.
Immune-mediated inflammatory diseases: progress in molecular pathogenesis and therapeutic strategies.
Melatonin controls experimental autoimmune encephalomyelitis by altering the T effector/regulatory balance.
Benign course of tumour-like multiple sclerosis. Report of five cases and literature review.
Respiratory muscle training for respiratory deficits in neurodegenerative disorders: a systematic review.
The influence of executive functions and memory on self-generation benefit in persons with multiple sclerosis.
Multiplex qPCR assay for ultra sensitive detection of JCV DNA with simultaneous identification of genotypes that discriminates non-virulent from virulent variants.
Strategies used by individuals with multiple sclerosis and with mild disability to maintain dynamic stability during a steering task.
The innate immune system in demyelinating disease.
Knowledge and attitude assessment of Iranian multiple sclerosis patients receiving interferon beta.
CSF neurofilament and N-acetylaspartate related brain changes in clinically isolated syndrome.
Sphingosine 1-Phosphate Receptor 1 as a Useful Target for Treatment of Multiple Sclerosis.
Genetic pleiotropy between multiple sclerosis and schizophrenia but not bipolar disorder: differential involvement of immune-related gene loci.
Mitochondrial DNA sequence variation in multiple sclerosis.
Longitudinally extensive varicella-zoster virus myelitis in a multiple sclerosis patient.
Quantitative evaluation of CXCL8 and its receptors (CXCR1 and CXCR2) gene expression in Iranian patients with multiple sclerosis.
New and emerging immune-targeted drugs for the treatment of multiple sclerosis.
Oral treatment with the herbal formula B401 protects against aging-dependent neurodegeneration by attenuating oxidative stress and apoptosis in the brain of R6/2 mice.
Subacute sclerosing panencephalitis presenting as neuromyelitis optica.
A changing treatment landscape for multiple sclerosis: challenges and opportunities.
Adherence to Glatiramer Acetate 40 Mg Versus Oral Disease-Modifying Therapies for Multiple Sclerosis.

Pages